presence of p53 will inhibit the function of apoptosis
(Cancer Research Center, 2011). In addition, there is
a relationship between anticancer and antioxidants
because antioxidants can trap free radicals which are
one of the agents that cause breast cancer in humans.
Therefore, this study aims to determine the
antioxidant activity of ethanol extract of okra fruit
(Abelmoshcus esculentus L. (Moench)) and its effect
on the expression of p53 protein in breast cancer
induced by benzo(α)pyrene so it can become a
source of information for those who need to be
developed into an alternative cancer treatment,
especially breast cancer with raw materials derived
from plants.
2 MATERIALS AND METHOD
This research has been conducted at the Pharmacy
Research Laboratory, Organic Chemistry Laboratory,
Laboratory of Structure and Animal Development,
Faculty of Mathematics and Natural Sciences
(FMIPA) and Anatomy Pathology Laboratory,
Faculty of Medicine, University of North Sumatra.
2.1 Research Design
This study used a Completely Randomized Design
(CRD) with 5 treatments and 6 replications so that
the number of samples used was 30 samples, 30
female rats (Rattus sp) Wistar strains.
2.2 Extract Preparation
The okra fruit was obtained from the Growth Center
Laboratory of KOPWIL 1, North Sumatra. After
being collected from the field, the okra fruit that has
been washed clean is dried in an oven at 40
o
C until it
meets the requirements of general moisture content.
Simplisia that is dried and then made into powder
until smooth and sieved with a B
30
sieve. Making
ethanol extract of okra fruit is done by maceration,
ie okra fruit powder is put into a brown bottle and
ethanol is added until submerged and then stirred
and left for 1 night. Take the filtrate and re-soak the
residue with ethanol until a clear filtrate is obtained.
The filtrate obtained was separated with a rotary
evaporator so that a thick extract was obtained.
2.3 Animal Preparation
The experimental animals used were rats (Rattus sp.)
of Wistar strains, female, healthy, aged 8-11 weeks,
with a weight of 200-250 g. Thirty animals obtained
from the North Sumatra Animal Disease
Investigation Center Medan. The animals were
placed in plastic cages with lids made of ram wire,
feed in the form of pellets and drinking water were
given ad libitum. The environment of the cage was
arranged with adequate ventilation and sufficient
light where the light time was 14 hours and the dark
time was 10 hours. Before experimenting, the mice
were adapted in a cage for 7 days. Rat health is
monitored every day.
2.4 Treatment Administration
Breast cancer induction was carried out by injecting
a solution of benzo(α)pyrene to the mammary tissue
of the rat. A single dose of 50 mg/kg body weight
was dissolved in olive oil and injected
subcutaneously. The emergence of tumor mass in
rat breast was observed by palpation for 4 months,
then continued with the administration of the ethanol
extract of okra (Abelmoschus esculentus L., Moech)
seed pods for 15 days. The animals were divided
into 5 groups:
a. A blank control group (K
0
): no treatment.
b. A positive control group (K
1
): single dose of
benzo(α)pyrene
c. Extract I group (P
1
): a single dose of
benzo(α)pyrene + 150 mg/kg body weight
extract.
d. Extract II group (P
2
): a single dose of
benzo(α)pyrene + 300 mg/kg body weight
extract.
e. Extract III group (P
3
): a single dose of
benzo(α)pyrene + 450 mg/kg body weight
extract.
2.5 Immunohistochemistry
The immunohistochemical method used in this study
is an indirect method with a brief procedure:
deparaffination, rehydration, and then immerse the
tissue section in peroxidase blocking solution at room
temperature for 10 minutes. The slides immersed in
a 25°C prediluted blocking serum for 10 minutes,
then incubated in a 25°C anti-p53 wild type primary
antibody for 10 minutes. After washed in phosphate
buffer saline (PBS) for 5 minutes, the slides
incubated in a secondary antibody solution at 25°C
for 10 minutes. The slides washed with PBS for 5
minutes then incubated in a freshly made diamino
benzidine (DAB) solution at 25°C for 10 minutes,
and then counterstained with haematoxylin.
Observations was conducted by calculating the
percentage of cells with p53 expressions and the